Clinical trial
Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment…
NCT00258635 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00258635 |
|---|---|
| Title | Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test |
| Official title | A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Ragweed Allergoid With MPL® With a Single-Blind Portion to Evaluate the Residual Allergenicity in Skin Test in Patients Sensitized to Ragweed Pollen. |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological |
| Interventions | RagweedMATAMPL |
| Enrollment | 69 |
| Start date | Nov 1, 2005 |
| Primary completion | Aug 7, 2006 |
| Completion | Aug 7, 2006 |
| First posted | Nov 28, 2005 |
| Last update posted | Jun 11, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: